Your Notifications
All done, no notifications

What is a Triple Vessel Disease?

Triple vessel disease refers to significant coronary artery disease involving the three major coronary territories, commonly the left anterior descending, left circumflex, and right coronary arteries. It usually develops from atherosclerotic plaque buildup and may reduce blood supply to the heart. Treatment depends on the extent and location of blockages, symptoms, heart function, and overall health.

What is the Importance of Timely Treatment?

Timely treatment can improve blood flow to the heart, control symptoms, reduce the risk of heart attack and heart failure, and help prevent further cardiovascular complications. Early assessment also helps determine whether medical therapy, angioplasty and stenting, or coronary artery bypass grafting (CABG) is most appropriate.

What are the Common Symptoms of Triple Vessel Disease?

  • Chest Pain or Discomfort: Pressure, tightness, heaviness, or squeezing in the chest, particularly during physical activity.
  • Shortness of Breath: Reduced blood flow to the heart may cause breathlessness during exertion.
  • Fatigue: Reduced cardiac efficiency may cause unusual tiredness or decreased exercise tolerance.
  • Pain in Other Areas: Discomfort may spread to the arm, shoulder, neck, jaw, back, or upper abdomen.
  • Palpitations: Some patients may experience a racing, pounding, or irregular heartbeat.
  • Dizziness or Sweating: Lightheadedness, cold sweating, nausea, or weakness may occur, particularly during an acute coronary event.

Causes and Risk Factors of Triple Vessel Disease

Causes

  • Atherosclerosis: Plaque buildup within the coronary arteries is the most common cause.
  • High LDL Cholesterol: Excess LDL cholesterol contributes to plaque formation.
  • High Blood Pressure: Long-term hypertension can damage artery walls and accelerate atherosclerosis.
  • Diabetes: Persistently elevated blood glucose can increase vascular damage and plaque formation.
  • Smoking: Tobacco exposure damages blood vessels and increases cardiovascular risk.

Risk Factors

  • Increasing age
  • High blood pressure
  • High LDL cholesterol
  • Diabetes
  • Smoking or tobacco use
  • Obesity
  • Physical inactivity
  • Unhealthy diet
  • Family history of premature coronary artery disease
  • Chronic kidney disease

Latest Research and Technologies in the Treatment of Triple Vessel Disease in Turkey

  • Recent advances include CT coronary angiography, fractional flow reserve (FFR), intravascular ultrasound (IVUS), and optical coherence tomography (OCT) for detailed assessment of coronary anatomy and blood flow. Modern treatment uses personalised risk assessment, intensive medical therapy, advanced drug-eluting stents, and improved PCI techniques. For patients with complex multivessel disease, coronary artery bypass grafting (CABG) remains an important treatment option, with advanced surgical planning and minimally invasive approaches available in selected centres.

Treatment options for Triple Vessel Disease

Coronary Artery Bypass Grafting (CABG) : Often preferred for patients with complex multivessel disease, particularly when diabetes, high anatomical complexity, or other factors favour surgery. The decision should be made by a multidisciplinary heart team.


Cost Start From 7000Explore Options

Angioplasty and Stenting: May be considered for selected patients when the coronary anatomy is suitable for PCI, particularly when surgical risk is high, or disease complexity is lower.

Hybrid or Minimally Invasive Procedures: In selected patients, a combination of minimally invasive bypass surgery and PCI may be considered when it offers advantages over either approach alone.

  • Clinical assessment:
    • Medical History: Assessment of chest pain, breathlessness, exercise tolerance, cardiovascular risk factors, previous heart disease, and family history.
    • Physical Examination: Evaluation of blood pressure, heart rate, weight, and other cardiovascular findings.
    • Electrocardiogram (ECG): Assesses heart rhythm and may identify evidence of ischemia or previous heart damage.
    • Blood Tests: Lipid profile, glucose, HbA1c, kidney function, and cardiac biomarkers when clinically indicated.
    • Stress Testing: Exercise or pharmacological stress testing may assess myocardial blood supply and exercise-related symptoms.
  • Imaging Tests:
    • Coronary Angiography: The invasive test for defining the location and severity of coronary blockages and planning revascularisation.
    • CT Coronary Angiography: Provides detailed images of coronary anatomy and may be useful in selected patients.
    • Echocardiography: Evaluates heart structure, pumping function, and regional wall motion.
    • Cardiac MRI: Provides detailed assessment of heart function, myocardial viability, and scarring in selected patients.
    • Nuclear Cardiac Imaging: May assess myocardial perfusion and identify areas with reduced blood flow.
    • IVUS: Provides detailed images of coronary arteries from inside the vessel during selected interventions.
    • OCT: Provides high-resolution images of coronary plaques and stents during selected procedures.
    • FFR/iFR: Physiological measurements can help determine whether specific coronary narrowings significantly affect blood flow.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive tele-rehabilitation services designed to support Triple Vessel Disease patients in Turkey. These services include:

  • Cardiac Rehabilitation: Structured rehabilitation can support recovery and improve cardiovascular fitness.
  • Gradual Physical Activity: Increase activity according to heart function, symptoms, and medical advice.
  • Weight Management: Maintaining a healthy weight supports heart health.
  • Medicines for triple-vessel disease may include statins or other lipid-lowering therapies, antiplatelet medicines, beta-blockers, nitrates, blood-pressure medicines, and diabetes medications, depending on the patient's condition. Treatment is individualised according to symptoms, coronary anatomy, heart function, cardiovascular risk, and whether revascularisation has been performed.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Triple Vessel Disease in Turkey

Medicana Bahcelievler Hospital: Top Doctors, and Reviews
Medicana Bahcelievler Hospital

Istanbul, Turkey

Medicana Bahcelievler Hospital located in Istanbul, Turkey is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

  • Capacity of 89 beds
  • 6 Operating Rooms
  • 2 Delivery Rooms
  • Coronary Intensive Care Unit
  • General Intensive Care Unit
  • Neonatal Intensive Care Unit
  • Dialysis Unit with 30 beds
Message Us
Medicana Konya Hospital: Top Doctors, and Reviews
Medicana Konya Hospital

Konya, Turkey

Medicana Konya Hospital located in Konya, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • Providing services in a closed area of 30.000 m2
  • It has a total of 80 physicians (including 32 specialist physicians), 37 academicians, 8 practitioners, 1 psychologist and 2 Dieticians
  • General and Neonatal Intensive Care Units
  • Total bed capacity for 223 beds with 49 in general intensive care, 7 in cardiovascular surgery intensive care, 9 beds in coronary intensive care unit, 41 in NICU and 117 service beds
  • Operating rooms are equipped with the latest medical technologies & state-of-the-art equipment like IT, MRI (1.5 Tesla), Mammography, Ultrasonography, etc.
  • Laboratories and Imaging Units
  • UHA Unit for International Patients
  • Pharmacies on Duty
  • Hospital rooms are categorized as Standard rooms and Suite rooms
  • Rooms are fully equipped with basic needs of a patient and their relatives, like TV, Mini Fridge, Nurse call system, telephone, central air conditioning ventilation system, etc.
  • 24-hour cafeteria
  • Parking lot
  • Mens & Womens Place of worship
Message Us
Medicana Bursa Hospital: Top Doctors, and Reviews
Medicana Bursa Hospital

Bursa, Turkey

Medicana Bursa Hospital located in Bursa, Turkey is accredited by ISO, JCI. Also listed below are some of the most prominent infrastructural details:

  • Covers an indoor area of 40,000 sqm
  • 22-storey building
  • Capacity of 300 beds (100 intensive care beds and 200 single rooms)
  • Intensive care units with general intensive care units (reanimation)
  • Operating rooms are available for all kinds of surgeries
  • Cardiovascular surgery ICU
  • Neonatal ICU (NICU)
  • Coronary ICU
  • Emergency room
  • Bursa Hospital provides a 5-star hotel comfort to its patients and their relatives
  • Cinema and Conference hall with Medical explanations
  • Rest areas
  • Cafeteria
  • Game and Hobby sections for children
  • Dining room (designed for 1000 employees)
  • Terrace Rest Area
Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose Turkey for Triple Vessel Disease Treatment?

  • Experienced Cardiac Specialists: Access to cardiologists, interventional cardiologists, and cardiac surgeons experienced in complex coronary disease.
  • Advanced Coronary Diagnostics: Major cardiac centres may offer coronary angiography, CT coronary angiography, IVUS, OCT, FFR, and advanced cardiac imaging.
  • Modern Interventional Cardiology: Eligible patients may have access to advanced PCI techniques and contemporary drug-eluting stents.
  • Advanced Cardiac Surgery: Specialised centres provide CABG and selected minimally invasive or hybrid surgical approaches.
  • Multidisciplinary Care: Cardiologists, cardiac surgeons, anaesthesiologists, critical-care specialists, and rehabilitation teams can collaborate for complex cases.
  • Personalised Treatment Planning: Revascularisation decisions can consider coronary anatomy, symptoms, heart function, diabetes, kidney function, and overall surgical risk.
  • Comprehensive Rehabilitation: Cardiac rehabilitation and long-term risk-factor management can support recovery.
  • International Patient Support: Many major Turkish hospitals assist international patients with appointments, treatment coordination, accommodation, and follow-up.

Frequently Asked Questions

Triple vessel disease is a long-term coronary condition requiring ongoing management. Recovery depends on the treatment used. After CABG, recovery commonly takes several weeks to months, while recovery after angioplasty is generally shorter. Individual recovery varies.

Many patients with stable coronary disease can walk, but the appropriate level of activity depends on symptoms, coronary blockages, heart function, and treatment. After significant disease or a procedure, increase activity only with medical advice.

\Yes. Major cardiac centres in Turkey may offer advanced coronary assessment and treatment technologies, including coronary angiography, CT coronary angiography, FFR/iFR, IVUS, OCT, advanced PCI, drug-eluting stents, and CABG. The availability of specific technologies and procedures varies by hospital.

Many major Turkish hospitals have international patient departments that help overseas patients with medical records, appointments, treatment coordination, accommodation, interpretation (where available), and follow-up arrangements.

Choose a centre with experienced interventional cardiologists and cardiac surgeons, advanced coronary imaging, catheterisation facilities, CABG expertise, intensive cardiac care, and cardiac rehabilitation. Complex cases may benefit from multidisciplinary treatment planning.

The success rate depends on the severity and location of blockages, heart function, age, diabetes, kidney function, overall health, and the treatment performed. Major cardiac centres in Turkey perform advanced procedures, such as CABG and PCI. With the right patient selection and experienced cardiac teams, outcomes can match international standards.

Many Turkish cardiac centres have cardiologists, interventional cardiologists, and cardiac surgeons experienced in managing complex multivessel coronary disease through medical therapy, PCI, and CABG.

Risks depend on the treatment and the patient's overall health. Angioplasty may involve bleeding, blood-vessel injury, contrast reactions, or rarely a heart attack. CABG carries risks, including bleeding, infection, rhythm disturbances, stroke, kidney complications, and anaesthesia-related complications.

Triple vessel disease is a cardiovascular condition, not an injury. If you develop severe or persistent chest pain, breathlessness, cold sweating, fainting, or pain spreading to the arm, jaw, or back, seek emergency medical care immediately.

Triple vessel disease does not directly cause physical or skeletal deformities. However, severe coronary disease or complications such as heart attack or heart failure may result in long-term limitations in physical capacity.

Yes. Chest discomfort, breathlessness, fatigue, reduced exercise capacity, and concerns about future cardiac events can affect daily life. Appropriate treatment, cardiac rehabilitation, and lifestyle management can help improve functional capacity and quality of life.

Yes. Untreated or poorly controlled triple vessel disease can increase the risk of heart attack, worsening angina, heart failure, abnormal heart rhythms, and other serious cardiovascular complications.

You can reduce risk by avoiding tobacco, controlling LDL cholesterol and blood pressure, managing diabetes, maintaining a healthy weight, following a heart-healthy diet, staying physically active, and taking prescribed medicines consistently. Regular cardiovascular follow-up is also important for people at increased risk.

Yes. Risk is higher in people with increasing age, diabetes, high blood pressure, high LDL cholesterol, smoking, obesity, physical inactivity, chronic kidney disease, or a family history of premature coronary artery disease.

Author

Pragun Gupta
Pragun Gupta

Doctor of Pharmacy

1 Year of Experience

Pragun Gupta is a Doctor of Pharmacy (Pharm. D.) professional from Teerthanker Mahaveer University with hands-on experience in clinical pharmacology, clinical research, and evidence-based medical writing. Through her clinical and research exposure, she has developed a strong interest in pharmacoeconomics, pharmacology, therapeutics, and pharmacovigilance.

As a medical writer, she works on medical and scientific research articles, patient education materials, and healthcare-focused content. Her clinical research and evidence-based writing experience enables her to translate complex medical information into clear, accurate, patient-friendly content while maintaining scientific credibility and medical accuracy. Her primary aim is to make healthcare information accessible and easy for patients and general readers to understand.

View More

Reviewer

Dr. Nityanand Tripathi
Dr. Nityanand Tripathi

Interventional Cardiologist

29 Years of Experience

With a rich experience of more than 29 years, Dr. Nityanand has gained a vast spectrum of skills and expertise in performing all types of complex cardiac procedures. He is an expert in clinical & interventional cardiology and electrophysiology. He studied his medicine (MBBS) and MD from the Institute of Medical Sciences of Banaras Hindu University, Varanasi, and later completed his DM in Cardiology from the prestigious King George Medical University, Lucknow. View More

Last Reviewed - January 2026